Literature DB >> 33393918

Research Priorities to End the Adolescent HIV Epidemic in the United States: Viewpoint.

M Isabel Fernandez1, Gary W Harper2, Lisa B Hightow-Weidman3, Bill G Kapogiannis4, Kenneth H Mayer5, Jeffrey T Parsons6, Mary Jane Rotheram-Borus7, Arlene C Seña3, Patrick S Sullivan8.   

Abstract

Youth represent 21% of new HIV diagnoses in the United States. Gay, bisexual, and transgender (GBT) youth, particularly those from communities of color, and youth who are homeless, incarcerated, in institutional settings, or engaging in transactional sex are most greatly impacted. Compared with adults, youth have lower levels of HIV serostatus awareness, uptake of antiretroviral therapy (ART), and adherence. Widespread availability of ART has revolutionized prevention and treatment for both youth at high risk for HIV acquisition and youth living with HIV, increasing the need to integrate behavioral interventions with biomedical strategies. The investigators of the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) completed a research prioritization process in 2019, focusing on research gaps to be addressed to effectively control HIV spread among American youth. The investigators prioritized research in the following areas: (1) innovative interventions for youth to increase screening, uptake, engagement, and retention in HIV prevention (eg, pre-exposure prophylaxis) and treatment services; (2) structural changes in health systems to facilitate routine delivery of HIV services; (3) biomedical strategies to increase ART impact, prevent HIV transmission, and cure HIV; (4) mobile technologies to reduce implementation costs and increase acceptability of HIV interventions; and (5) data-informed policies to reduce HIV-related disparities and increase support and services for GBT youth and youth living with HIV. ATN's research priorities provide a roadmap for addressing the HIV epidemic among youth. To reach this goal, researchers, policy makers, and health care providers must work together to develop, test, and disseminate novel biobehavioral interventions for youth. ©M Isabel Fernandez, Gary W Harper, Lisa B Hightow-Weidman, Bill G Kapogiannis, Kenneth H Mayer, Jeffrey T Parsons, Mary Jane Rotheram-Borus, Arlene C Seña, Patrick S Sullivan. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 04.01.2021.

Entities:  

Keywords:  HIV/AIDS; adolescents

Year:  2021        PMID: 33393918      PMCID: PMC7813632          DOI: 10.2196/22279

Source DB:  PubMed          Journal:  JMIR Res Protoc        ISSN: 1929-0748


  91 in total

1.  Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.

Authors:  David R Bangsberg
Journal:  Clin Infect Dis       Date:  2006-08-23       Impact factor: 9.079

Review 2.  Understanding adolescence as a period of social-affective engagement and goal flexibility.

Authors:  Eveline A Crone; Ronald E Dahl
Journal:  Nat Rev Neurosci       Date:  2012-09       Impact factor: 34.870

3.  LGBTQ Bullying: Translating Research to Action in Pediatrics.

Authors:  Valerie A Earnshaw; Sari L Reisner; Jaana Juvonen; Mark L Hatzenbuehler; Jeff Perrotti; Mark A Schuster
Journal:  Pediatrics       Date:  2017-10       Impact factor: 7.124

4.  Youth and Caregiver Perspectives on Barriers to Gender-Affirming Health Care for Transgender Youth.

Authors:  Samantha J Gridley; Julia M Crouch; Yolanda Evans; Whitney Eng; Emily Antoon; Melissa Lyapustina; Allison Schimmel-Bristow; Jake Woodward; Kelly Dundon; RaNette Schaff; Carolyn McCarty; Kym Ahrens; David J Breland
Journal:  J Adolesc Health       Date:  2016-05-24       Impact factor: 5.012

5.  African American experiences in healthcare: "I always feel like I'm getting skipped over".

Authors:  Adolfo G Cuevas; Kerth O'Brien; Somnath Saha
Journal:  Health Psychol       Date:  2016-05-12       Impact factor: 4.267

6.  Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.

Authors:  S Scott Sutton; Joseph Magagnoli; James W Hardin
Journal:  Pharmacotherapy       Date:  2017-02-03       Impact factor: 4.705

7.  A longitudinal study of the prevalence, development, and persistence of HIV/sexually transmitted infection risk behaviors in delinquent youth: implications for health care in the community.

Authors:  Erin Gregory Romero; Linda A Teplin; Gary M McClelland; Karen M Abram; Leah J Welty; Jason J Washburn
Journal:  Pediatrics       Date:  2007-05       Impact factor: 7.124

Review 8.  Efficacy of computer technology-based HIV prevention interventions: a meta-analysis.

Authors:  Seth M Noar; Hulda G Black; Larson B Pierce
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

9.  HIV testing in nonhealthcare facilities among adolescent MSM.

Authors:  Mariette R Marano; Renee Stein; Weston O Williams; Guoshen Wang; Songli Xu; Gary Uhl; Qi Cheng; Catherine N Rasberry
Journal:  AIDS       Date:  2017-07-01       Impact factor: 4.177

10.  PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015.

Authors:  Dawn K Smith; Maria C B Mendoza; Jo Ellen Stryker; Charles E Rose
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more
  2 in total

1.  Acceptability and Feasibility of Peer-to-Peer Text Messaging Among Adolescents to Increase Clinic Visits and Sexually Transmitted Infection Testing: Interrupted Times-Series Analysis.

Authors:  Marguerita Lightfoot; Joi Jackson-Morgan; Lance Pollack; Ayanna Bennett
Journal:  JMIR Form Res       Date:  2022-06-09

2.  Behavioral Efficacy of a Sexual Health Mobile App for Men Who Have Sex With Men: Randomized Controlled Trial of Mobile Messaging for Men.

Authors:  Patrick Sean Sullivan; Rob Stephenson; Sabina Hirshfield; Cyra Christina Mehta; Ryan Zahn; Jose A Bauermeister; Keith Horvath; Mary Ann Chiasson; Deborah Gelaude; Shelby Mullin; Martin J Downing; Evelyn Jolene Olansky; Sarah Wiatrek; Erin Q Rogers; Eli Rosenberg; Aaron J Siegler; Gordon Mansergh
Journal:  J Med Internet Res       Date:  2022-02-02       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.